Annoyed by AI summaries taking over your search results page? There's no official way to turn them off, but there are a few tricks you can try to stop seeing them so often.

Economist Peter Schiff questioned on Thursday how Strategy Inc. (NASDAQ:MSTR) can sustain the 11% dividend payout on its ...

AI Overviews appeared on more than 82% of health-related searches in Germany. YouTube was the most cited domain in AI Overview sources, ahead of medical and government sites. The Guardian reported ...

Ever feel like creating custom columns in Power Query is more frustrating than it should be? The process can often feel overwhelming, especially when you’re juggling null values, complex calculations, ...

In my years as a dietitian, I can’t possibly count how many clients have come to me with the idea that it was essential to eat several small meals a day to “stay ahead of hunger.” The subtext was ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

I am a woman in my mid-50s who after being trained and working in multiple sectors since I was a teenager is (finally) in a field I truly enjoy. It doesn’t pay much but gives me one of a few reasons ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...